SCHEMBL20109580

SCHEMBL20109580

CC1(C)OB(c2ccc3oc4cc5c6ccccc6c6ccccc6c5cc4c3c2)OC1(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPL P06858 10/20 0.45
LIPG Q9Y5X9 10/20 0.45
CSF1R P07333 1/20 0.39
EGFR P00533 2/20 0.38
PRMT5 O14744 1/20 0.37
WDR77 Q9BQA1 1/20 0.37
MAOA P21397 1/20 0.36
AHR P35869 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
P4HB P07237 1/20 0.35
PGR P06401 1/20 0.35
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22155557 0.94 LPL (0.43) LPLLIPGCSF1REGFRPRMT5
SCHEMBL20321608 0.93 LPL (0.46) LPLLIPGCSF1REGFRPRMT5
SCHEMBL16999818 0.91 MAOA (0.46) LPLLIPGCSF1REGFRPRMT5
SCHEMBL21066305 0.91 LPL (0.45) LPLLIPGCSF1RPRMT5WDR77
SCHEMBL2037575 0.89 LPL (0.49) LPLLIPGCSF1REGFRPRMT5
SCHEMBL26819697 0.89 LIPG (0.50) LPLLIPGCSF1REGFRPRMT5
SCHEMBL21888142 0.88 LPL (0.42) LPLLIPGCSF1REGFRPRMT5
SCHEMBL1343041 0.87 LPL (0.47) LPLLIPGCSF1REGFRPRMT5
SCHEMBL24169794 0.86 LIPG (0.48) LPLLIPGCSF1REGFRPRMT5
SCHEMBL21755943 0.86 LIPG (0.48) LPLLIPGCSF1RPRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11239435-B2 Iridium complex and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-02-01 US disclosed
US-11038124-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2021-06-15 US disclosed
US-11038124-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2021-06-15 US disclosed
US-20200235306-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-07-23 US disclosed
US-20200235320-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-07-23 US disclosed
US-20200235318-A1 IRIDIUM COMPLEX AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-07-23 US disclosed
US-20200235320-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-07-23 US disclosed
US-20200111971-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-04-09 US disclosed
US-20180123048-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2018-05-03 US disclosed
US-20180123048-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200235318-A1 IRIDIUM COMPLEX AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OPA1, MT-ND5, IMPA1 LPL 3121/4885LIPG 3952/4885CSF1R 2945/4885
US-11038124-B2 Organic compound and organic electroluminescence device using the same TRPA1, TRPC6, TRPM4 LPL 2258/4885LIPG 2394/4885CSF1R 4527/4885
US-20200111971-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME TRPA1, TRPC6, TRPM4 LPL 2258/4885LIPG 2394/4885CSF1R 4527/4885
US-11239435-B2 Iridium complex and organic electroluminescence device using the same OPA1, MT-ND5, IMPA1 LPL 3121/4885LIPG 3952/4885CSF1R 2945/4885
US-20180123048-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF PIEZO1, OCIAD1, LEF1 LPL 2598/4885LIPG 1295/4885CSF1R 3453/4885
US-20200235306-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, PIEZO1, ODC1 LPL 2133/4885LIPG 2787/4885CSF1R 4247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.